Capricor Therapeutics
CAPR
$4.64
Share price
-3.13%
Change (1 day)
-5.69%
Change (1 year)
Categories
Capricor Therapeutics (CAPR) - Total assets
Total assets on the balance sheet as of March 2024 : $49.44 M
According to Capricor Therapeutics 's latest financial reports the company's total assets are $49.44 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $58.73 M | 17.25% |
| 2022-12-31 | $50.09 M | 21.21% |
| 2021-12-31 | $41.33 M | 19.39% |
| 2020-12-31 | $34.61 M | 211.5% |
| 2019-12-31 | $11.11 M | 20.19% |
| 2018-12-31 | $9.24 M | -43.18% |
| 2017-12-31 | $16.27 M | -13.19% |
| 2016-12-31 | $18.74 M | 16.66% |
| 2015-12-31 | $16.06 M | 17.88% |
| 2014-12-31 | $13.63 M | 146.16% |
| 2013-12-31 | $5.53 M | 2.11% |
| 2012-12-31 | $5.42 M | 295.26% |
| 2011-12-31 | $1.37 M | -62.57% |
| 2010-12-31 | $3.66 M | 1.28% |
| 2009-12-31 | $3.61 M | -43.75% |
| 2008-12-31 | $6.43 M | -62.34% |
| 2007-12-31 | $17.08 M | |
| 2006-12-31 | $N/A | -100% |
| 2005-12-31 | $0 M | -55.75% |
| 2004-12-31 | $0 M | -41.15% |
| 2003-12-31 | $0 M | 4216% |
| 2002-12-31 | $0 M | -89.71% |
| 2001-12-31 | $0 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 347,696.72% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $3.47 B | 6,922.84% | 🇺🇸 USA |
 Cytokinetics
CYTK | $0.80 B | 1,534.32% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.86 B | 1,657.22% | 🇺🇸 USA |
 Palatin Technologies PTN | $11.4 M | -76.93% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $49.65 M | 0.43% | 🇺🇸 USA |